ENvue Medical, Inc. - Common Stock (FEED)
1.0300
+0.00 (0.00%)
NASDAQ · Last Trade: Oct 31st, 5:35 AM EDT
ENvue Medical Commences U.S. Production of UroShield(R) and Begins Fulfilling UK Distributor Orders
Shipments to Peak Medical underway under agreement with multi-million-dollar minimum purchase commitments through 2029; follows September start of PainShield® shipments in the U.S.
By ENvue Medical · Via ACCESS Newswire · October 29, 2026
ENvue Medical Issues Letter to Shareholders
Letter Highlights Inova Clinical Data, Hospital Customer Base and Leaner Operating Structure
By ENvue Medical · Via ACCESS Newswire · October 26, 2026
New to The Street Broadcasts Today on Bloomberg Across the U.S., MENA, and Latin America
This broadcast airs as sponsored programming and includes television commercials from NeOnc Technologies (NASDAQ:NTHI), Synergy CHC (NASDAQ:SNYR), DataVault AI (NASDAQ:DVLT), and The Sustainable Green Team (OTCQB:SGTM).
Via ACCESS Newswire · January 31, 2026
ENvue Medical Appoints Veteran Healthcare-Industry Executive, David Johnson, as Chairman
ENvue Medical, Inc. (NASDAQ: FEED) (“ENvue” or the “Company”), a medical technology company specializing in non-invasive therapeutic systems, today announced the appointment of David Johnson as Chairman of the Board. Mr. Johnson will work alongside CEO, Doron Besser, and the existing leadership team.
By ENvue Medical, Inc. · Via Business Wire · December 15, 2025